Evidence map›Paper›PMID 38793052›Full record

ArticleJournal of personalized medicine2024

The Prevalence of Risk Factors for Cardiovascular Diseases in Najran Region, Saudi Arabia.

Mohammad H Alyami, Hussain Mahdi Al-Slaim, Hamad Mana Alzamanan, Mohammad F Bayan, Khalid Ahmed

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad H AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.ORCID 0000-0003-2731-1071
Hussain Mahdi Al-SlaimDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.
Hamad Mana AlzamananDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.
Mohammad F BayanFaculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0002-1736-1799
Khalid AhmedDepartment of Clinical Pharmacy, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.ORCID 0000-0001-9698-2448

Funding

Deanship of Scientific Research at Najran University NU/RG/MRC/12/20
6 · The paper itself

Abstract

The primary goal of this study was to investigate the knowledge, prevalence, and risk factors of cardiovascular diseases among individuals in the Najran region of Saudi Arabia. In the Najran region of Saudi Arabia, an online cross-sectional survey was conducted. Between September and October 2023, a self-administered questionnaire was distributed to a random sample of the general population aged 18 and up. The survey instrument asked about history and exposure, physician-diagnosed illnesses, cardiovascular diseases (CVDs), medication use, and other risk factors. This research had a total of 2046 individuals. Around one-fifth of the study participants reported that they or a family member suffered from CVD, and arrhythmia was the most commonly reported; blood tests, cardiac catheterization, and ECG were the most commonly reported tests performed for CVD patients, around one-tenth of CVD patients reported that they do not have any chronic diseases other than CVD, and the vast majority of the patients confirmed their regular medical appointments. This is one of the first studies to investigate the knowledge, prevalence, and use of CVD drugs among individuals in the Najran region of Saudi Arabia. The study participants' lack of knowledge about CVD could lead to ineffective preventive measures and poor patient outcomes. The study's findings underscore the crucial need for more extensive and efficient educational initiatives that consider the targeted population's talents, attitudes, and perceptions.

Indexed as

cardiovascularcommunity awarenessNajranSaudi Arabia

Identifiers

PMID38793052
PMCPMC11122554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.